Work

A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.2050

Authors: G. R. Simon, P. A. Janne, C. Langer, V. Clarie, A. Dowlati, S. M. Gadgeel, K. Kelly, Z. Ye, C. K. Obasaju, K. E. Hood, H. L. Kindler

Institutions: Fox Chase Cancer Center, Eli Lilly (United States), University of New Mexico, Wayne State University, Moffitt Cancer Center, University of Chicago, University of Colorado Health, Dana-Farber Cancer Institute, Case Western Reserve University

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603203952

Cites:

Cited by:

Related to: 10